Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Similar articles for PubMed (Select 19915462)

1.

The distinction of metabolically 'healthy' from 'unhealthy' obese individuals.

Blüher M.

Curr Opin Lipidol. 2010 Feb;21(1):38-43. doi: 10.1097/MOL.0b013e3283346ccc. Review.

PMID:
19915462
2.

Are there still healthy obese patients?

Blüher M.

Curr Opin Endocrinol Diabetes Obes. 2012 Oct;19(5):341-6. doi: 10.1097/MED.0b013e328357f0a3. Review.

PMID:
22895358
3.

Adipose tissue dysfunction in obesity.

Blüher M.

Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):241-50. doi: 10.1055/s-0029-1192044. Epub 2009 Apr 8. Review.

PMID:
19358089
4.

The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.

Bonen A, Tandon NN, Glatz JF, Luiken JJ, Heigenhauser GJ.

Int J Obes (Lond). 2006 Jun;30(6):877-83.

PMID:
16418758
5.

Adipose tissue inflammation and insulin resistance: all obese humans are not created equal.

Gauthier MS, Ruderman NB.

Biochem J. 2010 Sep 1;430(2):e1-4. doi: 10.1042/BJ20101062.

PMID:
20704568
6.

[Pharmacological therapy of obesity].

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian.

PMID:
18773755
7.

Are there persons who are obese, but metabolically healthy?

Sims EA.

Metabolism. 2001 Dec;50(12):1499-504. Review. Erratum in: Metabolism 2002 Apr;51(4):536.

PMID:
11735101
8.

Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.

Bays HE, González-Campoy JM, Bray GA, Kitabchi AE, Bergman DA, Schorr AB, Rodbard HW, Henry RR.

Expert Rev Cardiovasc Ther. 2008 Mar;6(3):343-68. doi: 10.1586/14779072.6.3.343. Review.

PMID:
18327995
9.

Exercise in weight management of obesity.

Poirier P, Després JP.

Cardiol Clin. 2001 Aug;19(3):459-70. Review.

PMID:
11570117
10.

Metabolically obese normal weight and phenotypically obese metabolically normal youths: the CASPIAN Study.

Kelishadi R, Cook SR, Motlagh ME, Gouya MM, Ardalan G, Motaghian M, Majdzadeh R, Ramezani MA.

J Am Diet Assoc. 2008 Jan;108(1):82-90.

PMID:
18155992
11.

Identification and characterization of metabolically benign obesity in humans.

Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU.

Arch Intern Med. 2008 Aug 11;168(15):1609-16. doi: 10.1001/archinte.168.15.1609.

PMID:
18695074
12.

The metabolically obese, normal-weight individual revisited.

Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S.

Diabetes. 1998 May;47(5):699-713. Review.

PMID:
9588440
13.

Obesity, insulin resistance, and cardiovascular disease.

Reaven G, Abbasi F, McLaughlin T.

Recent Prog Horm Res. 2004;59:207-23. Review.

PMID:
14749503
14.

Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.

Viljanen AP, Lautamäki R, Järvisalo M, Parkkola R, Huupponen R, Lehtimäki T, Rönnemaa T, Raitakari OT, Iozzo P, Nuutila P.

Ann Med. 2009;41(2):152-60. doi: 10.1080/07853890802446754.

PMID:
18855190
15.

Metabolic obesity: the paradox between visceral and subcutaneous fat.

Hamdy O, Porramatikul S, Al-Ozairi E.

Curr Diabetes Rev. 2006 Nov;2(4):367-73. Review.

PMID:
18220642
16.

Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk.

Després JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E, Rodés-Cabau J, Bertrand OF, Poirier P.

Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49. doi: 10.1161/ATVBAHA.107.159228. Epub 2008 Mar 20. Review. Erratum in: Arterioscler Thromb Vasc Biol. 2008 Jul;28(7):e151.

17.

Intra-abdominal obesity: an untreated risk factor for Type 2 diabetes and cardiovascular disease.

Després JP.

J Endocrinol Invest. 2006;29(3 Suppl):77-82. Review.

PMID:
16751711
18.

[Metabolically obese normal-weight individuals and metabolically healthy, but obese, subjects].

Beck E, Esser N, Paquot N, Scheen AJ.

Rev Med Suisse. 2009 Aug 26;5(214):1644-6, 1648-9. Review. French.

PMID:
19772195
19.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

20.

Childhood obesity, adipose tissue distribution, and the pediatric practitioner.

Slyper AH.

Pediatrics. 1998 Jul;102(1):e4. Review.

PMID:
9651456
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk